CVRx, Inc. Common Stock (CVRX)

Price$5.38

Value ScoreC

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-53.08%

Price vs S&P 500 (4W)-21.22%

VGM Score55.38

Market Capitalization$142.76M

All Metrics

Book Value / Share (Quarterly)$1.10

P/TBV (Annual)3.82x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)36.10%

Cash Flow / Share (Quarterly)$-1.52

Price vs S&P 500 (YTD)-32.38%

Gross Margin (TTM)86.18%

Net Profit Margin (TTM)-89.15%

EPS (TTM)$-2.01

10-Day Avg Trading Volume0.24M

EPS Excl Extra (TTM)$-2.01

Revenue Growth (5Y)56.42%

EPS (Annual)$-2.04

ROI (Annual)-60.00%

Gross Margin (Annual)85.33%

Net Profit Margin (5Y Avg)-166.12%

Cash / Share (Quarterly)$2.74

Revenue Growth QoQ (YoY)19.61%

ROA (Last FY)-50.87%

Revenue Growth TTM (YoY)11.73%

EBITD / Share (TTM)$-1.88

ROE (5Y Avg)-68.33%

Operating Margin (TTM)-84.62%

Cash Flow / Share (Annual)$-1.55

P/B Ratio4.90x

P/B Ratio (Quarterly)8.55x

Net Income / Employee (Annual)$-239,000

EV / Revenue (TTM)2.18x

Net Interest Coverage (TTM)-8.15x

ROA (TTM)-48.38%

EPS Incl Extra (Annual)$-2.04

Current Ratio (Annual)7.63x

Quick Ratio (Quarterly)8.58x

3-Month Avg Trading Volume0.33M

52-Week Price Return-16.72%

Revenue / Employee (TTM)$264,900

Tangible BV / Share (Quarterly)$3.98

P/S Ratio (Annual)2.52x

Asset Turnover (Annual)0.54x

52-Week High$11.30

Operating Margin (5Y Avg)-137.77%

EPS Excl Extra (Annual)$-2.04

CapEx CAGR (5Y)13.35%

26-Week Price Return-45.16%

Quick Ratio (Annual)6.49x

13-Week Price Return-35.72%

Total Debt / Equity (Annual)1.26x

Current Ratio (Quarterly)10.20x

Enterprise Value$128.95M

Revenue / Share Growth (5Y)47.26%

Asset Turnover (TTM)0.54x

Revenue / Employee (Annual)$254,000

Inventory Turnover (Annual)0.68x

Pretax Margin (Annual)-94.13%

Cash / Share (Annual)$2.88

3-Month Return Std Dev85.02%

Gross Margin (5Y Avg)80.60%

Net Income / Employee (TTM)$-236,100

ROE (Last FY)-135.56%

Net Interest Coverage (Annual)-7.90x

EPS Basic Excl Extra (Annual)$-2.04

Receivables Turnover (TTM)6.52x

Total Debt / Equity (Quarterly)2.01x

EPS Incl Extra (TTM)$-2.01

Receivables Turnover (Annual)5.68x

ROI (TTM)-55.25%

P/S Ratio (TTM)2.42x

Pretax Margin (5Y Avg)-165.79%

Revenue / Share (Annual)$2.17

Tangible BV / Share (Annual)$5.29

Price vs S&P 500 (52W)-41.08%

Year-to-Date Return-24.23%

5-Day Price Return-0.92%

EPS Normalized (Annual)$-2.04

ROA (5Y Avg)-38.60%

Net Profit Margin (Annual)-94.10%

Month-to-Date Return-3.58%

Cash Flow / Share (TTM)$-2.03

EBITD / Share (Annual)$-1.94

Operating Margin (Annual)-90.49%

LT Debt / Equity (Annual)1.26x

ROI (5Y Avg)-42.85%

LT Debt / Equity (Quarterly)2.01x

EPS Basic Excl Extra (TTM)$-2.01

P/TBV (Quarterly)5.03x

P/B Ratio (Annual)4.73x

Inventory Turnover (TTM)0.68x

Pretax Margin (TTM)-89.17%

Book Value / Share (Annual)$1.49

Price vs S&P 500 (13W)-43.98%

Beta0.78x

Revenue / Share (TTM)$2.24

ROE (TTM)-120.77%

52-Week Low$4.37

vGradeC

gGradeB

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.50est. -0.51

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

Industry Peers — Surgical & Medical Instruments(138)

Symbol	Value Score	Growth Score	Momentum Score	Price
CVRXCVRx, Inc. Common Stock	C	B	D	$5.38
SYKStryker Corporation	C	C	C	$305.66
MMM3M Company	C	F	C	$153.76
BSXBoston Scientific Corp.	C	B	D	$48.55
MDLNMedline Inc. Class A common stock	C	D	D	$33.61
BDXBecton, Dickinson and Co.	B	C	C	$151.16
RMDResMed Inc.	C	B	C	$196.04
DXCMDexCom, Inc.	C	B	C	$72.86
WSTWest Pharmaceutical Services, Inc.	D	C	B	$314.50
SOLVSolventum Corporation	C	D	B	$81.01
PENPenumbra, Inc.	F	C	B	$320.53

About

CVRx Inc is a commercial-stage medical device company developing minimally invasive neuromodulation solutions for heart failure and other cardiovascular diseases. Its proprietary Barostim platform uses Baroreflex Activation Therapy to restore autonomic nervous system balance and improve cardiac function. The company generates revenue primarily from the U.S. market.